Astute Analytica released an extensive market assessment report titled “Global Ureteral stents market: Trends, Industry Competition Analysis, Revenue, and Forecast to 2033.” This report offers a deep ...

Detailed price information for Siemens Healthineers Ag (SEMHF) from The Globe and Mail including charting and trades.

We thank Manuela Tutolo and colleagues for commending the design of the FUTURE study and the robustness of its delivery, including the urodynamics quality control. We also thank Maurizio Serati and ...

Notice of Annual General Meeting 2025 The Annual General Meeting of Coloplast A/S will be held on Thursday, 4 December 2025 ...

Nicole Trimboli, 51, from Australia, first beat Hodgkin's Lymphoma in 2006, only to face a second devastating diagnosis of ...

Full year financial results. 1 October 2024 - 30 September 2025. Coloplast delivered Q4 organic growth of 7% and an EBIT margin 1 of 28%. Reported revenue in DKK grew 0% w ...

SEBOKENG – A state-of-the-art stoma clinic was recently launched at Sebokeng Hospital. The clinic, a product of a collaboration between the hospital and Coloplast, supported by OMS Medical, will ...

Coloplast interim CEO Lars Rasmussen has today informed the Coloplast Board of Directors that he will not stand for re-election as board member at the upcoming annual general meeting on December 4, ...

In addition to RBC Capital, Alcon also received a Buy from TR | OpenAI – 4o’s Jack Scalprey in a report issued today. However, on November 5, Barclays maintained a Hold rating on Alcon (NYSE: ALC).

Investing.com - Deutsche Bank has reduced its price target on Coloplast A/S (CSE:COLOB) to DKK660.00 from DKK708.00 while maintaining a Hold rating on the stock. According to InvestingPro data, the ...

Coloplast A/S ((GB:0QBO)) announced an update on their ongoing clinical study. Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst ...